Circulating tumor DNA as a promising biomarker of relapse risk for stage II-III colorectal cancer.

Authors

null

Gong Chen

Department of Colorectal Surgery, Sun Yat-Sen University Cancer Centre, Guangzhou, China

Gong Chen , Feng Wang , Jun-Jie Peng , San-Jun Cai , Ke-Feng Ding , Qian Xiao , Fu-Long Wang , Xiao-Jun Wu , Zhi-Zhong Pan , Pei-Rong Ding , Ling-Heng Kong , De-Sen Wan , Xiaojun Fan , Rui Liu , Hua Bao , Junli Zhang , Jiaohui Pang , Xue Wu , Yang Shao , Rui-hua Xu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Colorectal and Anal

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Epidemiology/Outcomes

Clinical Trial Registration Number

NCT03312374

Citation

J Clin Oncol 38: 2020 (suppl; abstr 4079)

DOI

10.1200/JCO.2020.38.15_suppl.4079

Abstract #

4079

Poster Bd #

71

Abstract Disclosures